4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-16-127439
Options or other derivatives
- Pres. & Chief Executive Offic acquired 82,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BRISTOW MICHAEL R Pres. & Chief Executive Offic | 2016-06-09 | Grant or award · Stock Option (right to buy) | +27,200 | 27,200 | D: show line 1 in the form | |||||
| BRISTOW MICHAEL R Pres. & Chief Executive Offic | 2016-06-09 | Grant or award · Stock Option (right to buy) | +55,400 | 55,400 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…